Delivery Order SPE2DR25D3012-SPE2DR26F4D0G
Award Date 12/8/25
Potential Completion Date 12/9/25
Potential Value $8.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $28,798.84 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $9,030.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes with an ultimate completion date of November 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,141.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on September 29, 2025, with completion scheduled for September 30, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,775.10 to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a $7,620.30 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes, with an ultimate completion date of December 12, 2025. This contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,215.15 to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a $3,570.63 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 12, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on August 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. Orencia (abatacept) is a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $6,365.41 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant used primarily in the treatment of rheumatoid arthritis...